US Executive Officer Management Changes SEC — April 13, 2026

13-04-2026

On April 7, 2026, ProFrac Holding Corp.'s Compensation Committee granted performance-based restricted stock unit (PSU) awards under the 2022 Long Term Incentive Plan to key executives: 287,500 PSUs each to Executive Chairman Matthew D. Wilks and CEO Johnathan L. Wilks, 270,000 PSUs to CFO Austin Harbour, and 150,000 PSUs to Chief Commercial Officer Matthew Greenwood, vesting subject to one-year service and stock price VWAP thresholds of $7-$18. Additionally, CFO Harbour received a special $1,000,000 cash incentive award payable in four $250,000 quarterly installments through December 31, 2026, subject to continued employment. No performance declines or negative metrics reported; awards aim to retain executive talent.

• ·PSUs require continuous employment through April 7, 2027 (Time-Based Vesting Date); unvested PSUs expire April 7, 2036, with negotiation for new incentives.
• ·CFO cash award first installment vested as of March 31, 2026; includes forfeiture and repayment clauses for voluntary termination or termination for Cause in 2026.
• ·VWAP measured over most recent 30 trading days; settlement within 30 days of vesting.

13-04-2026

Effective April 11, 2026, Mary L. Lentz retired from the Board of Directors of Independent Bank Corp. and Rockland Trust Company upon reaching the age of 72, in accordance with the company's Governance Principles mandating retirement at that age. She had served as a Director since 2016, a member of the Audit Committee since 2018, and the Risk Committee since 2024. The filing includes no financial impacts or other changes.

• ·Governance Principles require directors to retire upon attaining age 72
• ·Filing signed by Patricia M. Natale on April 13, 2026

13-04-2026

On April 7, 2026, Xenon Pharmaceuticals Inc. amended and restated its 2025 Inducement Equity Incentive Plan, increasing the maximum number of common shares reserved for issuance from 900,000 to 1,175,000 shares (a 30.6% increase). The plan is exclusively for inducement grants such as nonstatutory stock options, stock appreciation rights, restricted stock units, restricted stock, and performance awards to new hires or rehired employees following a bona fide interruption. No shareholder approval was sought, in accordance with Nasdaq Listing Rule 5635(c)(4).

• ·Filing date: April 13, 2026
• ·Exhibit 10.1: Amended and Restated 2025 Inducement Plan and related form agreements filed
• ·Plan amendments subject to adjustments as provided therein

13-04-2026

WEBTOON Entertainment Inc. (Nasdaq: WBTN) announced a restructured global leadership team under President Yongsoo Kim to accelerate growth, eliminating the Chief Operating Officer and Chief Technology Officer roles while creating a new Chief Business Officer position led by Leah Goeun Yeon. Key elevations include Yuki Chae to Chief Product Officer, Teo Taeyeong Jang to Head of AI, and Sean Shinhyung Kim to Head of IP Business; David J Lee will add President of Wattpad to his CFO duties. The changes unify operations across WEBTOON's ecosystem, which serves approximately 160 million monthly active users.

• ·Leadership changes effective as of April 13, 2026 filing date.
• ·All new roles report directly to President Yongsoo Kim, except David J Lee who reports to CEO Junkoo Kim as CFO.
• ·Chief Business Officer oversees growth, marketing, content, and creator management for Korean and Rest of World webcomic platform (excluding Japan).

13-04-2026

CMC announced the appointment of Michael “Mike” Dumais to its Board of Directors, effective June 23, 2026, increasing the board from nine to ten directors, with nine independent. Mr. Dumais brings over 30 years of leadership experience, most recently as Executive Vice President and Chief Transformation Officer at Raytheon Technologies Corporation, and previously in senior roles at United Technologies Corporation; he will serve on the Audit and Finance Committees. Chairman Robert S. Wetherbee and CEO Peter Matt highlighted his alignment with CMC's strategic priorities in operational excellence and growth.

• ·Mr. Dumais serves on the board of directors at Baker Hughes Company.
• ·Mr. Dumais earned a Bachelor of Science in Electrical Engineering from Virginia Tech, a Master of Science in Electrical Engineering from the University of Pennsylvania, and a Master of Business Administration from the Wharton School of the University of Pennsylvania.
• ·CMC is a Fortune 500 company headquartered in Irving, Texas, founded in 1915.

13-04-2026

Jack in the Box Inc. appointed Eduardo Luz, an experienced restaurant executive formerly CEO of P.F. Chang’s, as an independent director to support the company's transformation and board refreshment. David Goebel and Madeleine Kleiner will retire from the Board effective May 8, 2026, reducing its size to nine members. The changes reflect responsiveness to shareholder feedback amid efforts to drive same-store sales, reduce debt, and improve margins.

• ·Eduardo Luz has over 30 years of experience in restaurant and consumer goods industries.
• ·Appointment announced on April 13, 2026; retirements effective May 8, 2026.
• ·Board refreshment ongoing to align with evolving business needs.

13-04-2026

On April 7, 2026, Tennessee Valley Authority (TVA) entered into a separation and release agreement with Donald A. Moul, its President and Chief Executive Officer, providing him severance and retirement benefits consistent with TVA's Executive Severance Plan and Long-Term Incentive Plan. The 8-K filing was made on April 13, 2026, under Item 5.02 for officer departure. No details on the reasons for departure, succession plans, or financial impacts were disclosed.

• ·Filing signed by Thomas C. Rice, Executive VP and CFO
• ·TVA is a corporate agency of the United States created by an act of Congress

13-04-2026

Net Power Inc. appointed Ned Leland (Lee) Shuman as Chief Financial Officer effective April 13, 2026, replacing interim CFO Daniel J. Rice IV, who will remain CEO and serve as principal financial officer until the Q1 2026 10-Q filing. Mr. Shuman brings over 25 years of experience, including leading $1.6B in financings at WattBridge Energy for a 2.4 GW portfolio. Compensation includes $420,000 base salary, 60% STIP target bonus, 180% LTIP target, $800,000 RSU grant vesting over three years, and $100,000 cash bonus.

• ·Mr. Shuman previously served as Head of Power Finance at Javelin Global Commodities (April 2024-April 2026) and CFO of WattBridge Energy (2020-April 2024).
• ·No family relationships or special understandings regarding Mr. Shuman's selection.
• ·Mr. Shuman holds J.D. from University of Georgia, M.Tax and M.B.A. from Georgia State University, B.A. from Emory University.

13-04-2026

Solana Company announced on April 8, 2026, the mutual separation and resignation of its Chief Medical Officer, Antonella Favit-Van Pelt, MD, PhD, effective immediately. Under the separation agreement, the Company will pay Dr. Favit-Van Pelt a lump sum of $875,000 within ten business days, less withholdings, in exchange for a release of claims and ongoing compliance with confidentiality and invention assignment obligations. No successor has been named in the filing.

• ·Separation Agreement filed as Exhibit 10.1
• ·Report date: April 8, 2026; Filing date: April 13, 2026
• ·Company address: 642 Newtown Yardley Road, Suite 100, Newtown, PA 18940

13-04-2026

On April 7, 2026, the Compensation Committee of Vistagen Therapeutics, Inc. approved retention awards in the form of stock options to all company employees, including five key executives each receiving options to purchase 75,000 shares of common stock at an exercise price of $0.5358 per share. The options, granted under the Amended and Restated 2019 Omnibus Equity Incentive Plan, vest with 25% vesting six months after the grant date and the remainder in additional 25% installments every six months thereafter, becoming fully vested on the two-year anniversary. No departures, elections, or appointments of directors or officers were reported.

13-04-2026

On April 9, 2026, Mark Keeley resigned as Chief Financial Officer Consultant of Mobile Global Esports, Inc. Brett Rosin, the Company's Chief Executive Officer, will serve as the principal accounting officer on an interim basis until a new Chief Financial Officer is hired. The filing discloses no details on the reasons for the resignation or any compensatory arrangements.

• ·Company trades as MGAM on OTC Pink Sheets
• ·Emerging growth company status confirmed
• ·Principal executive offices: 500 Post Road East, 2nd Floor, Westport, CT 06883

13-04-2026

AdvanSix Inc. (NYSE: ASIX) announced the appointment of Patrick C. Day as Senior Vice President and Chief Financial Officer, effective April 27, 2026, reporting to President and CEO Erin Kane. Day, previously VP of Financial Planning and Analysis and Investor Relations at FMC Corporation, replaces interim CFO Christopher Gramm, who will continue as Vice President of Corporate Finance and Strategic Financial Planning & Analysis. The appointment is positioned as strengthening leadership for growth and value creation.

• ·Filing Date: April 13, 2026
• ·Appointment effective: April 27, 2026
• ·Day's education: Bachelor’s degree in finance from Elizabethtown College; Master’s degree in accounting and tax from the University of Connecticut

13-04-2026

Conagra Brands, Inc. (NYSE: CAG) announced the appointment of John Brase as President and Chief Executive Officer effective June 1, 2026, succeeding Sean Connolly who will step down from his leadership roles and the Board on May 31, 2026. Brase, with over 35 years of experience including roles at The J.M. Smucker Co. and Procter & Gamble where he led a $6B business, will also join the Board. The transition is described as smooth, with praise for Connolly's decade-long leadership in transforming Conagra into a pure-play food company generating fiscal 2025 net sales of nearly $12B.

• ·Brase previously oversaw U.S. retail, international, and Away from Home businesses at Smucker
• ·Conagra headquartered in Chicago
• ·Media contact: Mike Cummins (312-549-5257)
• ·Investor contact: Matthew Neisius (402-240-3226)

13-04-2026

Palvella Therapeutics, Inc. increased its Board of Directors from six to seven members and appointed John Doux, M.D., as a Class III director effective April 13, 2026, with term expiring at the 2026 Annual Meeting of Stockholders. Dr. Doux, a board-certified dermatologist with extensive experience in healthcare investments and prior service on the Company's board pre-reverse merger, was granted an option to purchase 6,000 shares of common stock vesting over 36 months per the Director Compensation Policy. The Board determined Dr. Doux to be independent under Nasdaq rules, with no related party transactions or family relationships.

• ·Dr. Doux, age 57, previously served on the Company's board from 2019 to 2022 prior to its reverse merger.
• ·No arrangements or understandings pursuant to which Dr. Doux was selected as director.
• ·Dr. Doux served on boards of multiple biotechnology companies, including Ceptaris Therapeutics acquired by Actelion.

13-04-2026

FedEx Corporation announced that Executive Vice President and Chief Financial Officer John W. Dietrich will step down from his role on June 1, 2026, and fully depart the company on July 31, 2026, with no disagreement on financial or operational matters. The Board of Directors appointed Claude F. Russ, current Enterprise Vice President, Finance, as Interim Chief Financial Officer effective June 1, 2026, while he retains his existing responsibilities and the company conducts an internal and external search for a permanent successor. Russ will receive additional compensation of $25,000 per month and a one-time $50,000 restricted stock unit award vesting over three years.

• ·John W. Dietrich’s departure is not due to any disagreement with the Company on financial controls, statements, operations, policies, or practices.
• ·FedEx and Mr. Dietrich expect to enter a separation and release agreement; details to be filed in an amendment to this 8-K within four business days of determination.
• ·Claude F. Russ has served in various FedEx roles since 2002, including Senior Vice President and CFO of FedEx Freight, and President/CEO of FedEx Dataworks.
• ·No family relationship between Claude F. Russ and any director or executive officer; no related transactions under Item 404(a) of Regulation S-K.

13-04-2026

Navitas Semiconductor (Nasdaq: NVTS) appointed Gregory M. Fischer, a semiconductor veteran with over 40 years of experience from Broadcom Inc., Semtech Corporation, and other firms, as an independent Class III director to its Board effective April 13, 2026. Fischer will serve on the Compensation and Executive Steering committees and stand for reelection in 2027, supporting the company's strategic transformation to high-power markets and Navitas 2.0 amid the AI revolution. Chairman Richard Hendrix highlighted Fischer's addition as key for management support in a competitive market.

• ·Fischer currently serves as an independent director of Semtech Corporation and advisor to Gerson Lehrman Group and AlphaSights Ltd.
• ·Fischer earned a B.S. in Electrical Engineering from the Milwaukee School of Engineering and an M.B.A. from the University of Iowa.
• ·Navitas is the world’s first semiconductor company to be CarbonNeutral®-certified.

13-04-2026

Mirion Technologies, Inc. entered into a Performance Stock Option Award Agreement with Thomas D. Logan on April 9, 2026, granting him performance stock options to purchase shares of Class A Common Stock, subject to service and performance conditions detailed in an attached Awards Summary Schedule (not provided). The options are divided into Tranche I (measurable at third anniversary of grant) and Tranche II (fourth anniversary), with payouts ranging from 0% to 150% of target based on performance relative to peers, and include pro-rata vesting for certain terminations post-Tranche I but forfeiture for cause. No specific target or maximum option counts, exercise price, or performance metrics are detailed in the filing excerpt.

• ·Pro Rata Amount denominator: 1,460 days (approx. 4 years)
• ·Expiration: earliest of termination for Cause or 7th anniversary of grant date
• ·Post-vest share sale restriction: 1 year
• ·CIC measurement: 60 trading days prior to 2 days before CIC Date
• ·Employment Agreement reference: August 13, 2021 (as amended)

13-04-2026

CG Oncology, Inc. appointed Jim DeTore, age 61, as Chief Financial Officer effective April 13, 2026, transitioning from his role as Interim Principal Financial and Accounting Officer since November 2025. Under the employment agreement, Mr. DeTore receives an initial annual base salary of $520,000, target annual bonus of 45% of base salary, initial stock option award with $4 million target value, and PSU award with $1 million target value, both granting on April 15, 2026. No other material changes or concerns such as family relationships or related-party transactions were reported.

• ·Stock options vest 25% after 12 months from April 13, 2026, then 36 equal monthly installments; PSUs vest 30% on first U.S. commercial sale of Company's first approved product and 70% on positive operating cash flow for two consecutive fiscal quarters post-launch.
• ·Severance includes 12 months base salary, prorated bonus, COBRA up to 12 months, and 12-month equity acceleration outside change-in-control; 1.5x base, full bonus, COBRA up to 18 months, full equity acceleration within change-in-control.
• ·Prior experience: CFO at Neurogastrx (June 2021-June 2025), independent CFO consultant to biotech/pharma (March 2017-May 2021), CFO at Proteostasis (Aug 2016-Feb 2017), CFO at Bluebird Bio (Nov 2014-Feb 2016).
• ·Company's principal executive offices now at 3000 Pegasus Park Drive, Suite 1640, Dallas, Texas 75247 (former: 400 Spectrum Center Drive, Suite 2040, Irvine, CA 92618).

13-04-2026

DarioHealth Corp. (NASDAQ: DRIO) announced the appointment of John R. Palumbo, a healthcare executive with over 40 years of experience including senior roles at AmerisourceBergen Corporation (now Cencora, Inc.) and Allscripts Healthcare Solutions, Inc. (now Veradigm, Inc.), to its Board of Directors on April 13, 2026. The appointment aims to support Dario's commercial scaling through partnerships with health systems and payers. CEO Erez Raphael emphasized Palumbo's strategic insight, operational expertise, and industry relationships to accelerate growth and value realization.

• ·Palumbo currently serves on boards of PM Pediatrics Management Group, LLC, Lucid Diagnostics Inc., ivWatch, LLC, and Qless, Inc., and chairs the advisory board of Brado Cuneo Nollau, LLC.
• ·Dario provides solutions for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health to health plans, employers, providers, and consumers.

13-04-2026

ALX Oncology Holdings Inc. (Nasdaq: ALXO) appointed Jeff Knight, M.P.H., as Chief Development and Operating Officer effective April 13, 2026, bringing over 30 years of biopharmaceutical experience from roles at Crinetics Pharmaceuticals, Poseida Therapeutics, Halozyme Therapeutics, Amgen, Onyx Pharmaceuticals, and Genentech. CEO Jason Lettmann highlighted Knight's expertise to support upcoming catalysts for evorpacept and ALX2004 clinical programs in the next 12-18 months. No financial impacts or performance metrics were disclosed.

• ·Appointment effective date: April 13, 2026
• ·Upcoming milestones timeframe: next 12 to 18 months
• ·Knight's education: Master of Public Health in Biostatistics and Epidemiology and Bachelor of Arts in Psychology from University of Oklahoma; Bachelor of Science in Nursing from University of Kansas

13-04-2026

Commvault announced two leadership appointments effective immediately: Gary Merrill as Chief Financial Officer (CFO), returning after serving in the role from 2022-2024 and most recently as Chief Commercial Officer, and Geoff Haydon as President of Customer and Field Operations, who is stepping down from the Board of Directors. Both report to President and CEO Sanjay Mirchandani, aiming to support growth in subscription/SaaS and customer operations. The company reaffirmed its fourth quarter and fiscal year 2026 guidance previously issued on January 27, 2026, with no changes indicated.

• ·Gary Merrill has over two decades at Commvault, including 15 years in finance.
• ·Next earnings conference call scheduled for April 28, 2026 at 8:30 a.m. EDT; webcast or dial-in (800) 715-9871 (toll-free) or (646) 307-1963 (international), event ID 5826149.

13-04-2026

AeroVironment, Inc. (AVAV) announced the appointment of Sean T. Woodward as Executive Vice President and Chief Financial Officer, effective May 1, 2026, succeeding Kevin McDonnell, who will remain in an advisory role through July 2026 to ensure a smooth transition. Woodward, with over 22 years of experience in defense technology including 15 years at AV, most recently served as CFO of AV's Autonomous Systems (AxS) segment and has contributed to the company's growth to roughly $10 billion market cap. CEO Wahid Nawabi praised Woodward's institutional knowledge and role in commercializing high-growth products.

• ·Appointment effective May 1, 2026
• ·McDonnell advisory role through July 2026
• ·Woodward holds BS in business management from University of South Florida and MBA in Finance from University of Tampa
• ·Investor contact: Denise Pacioni (ir@avinc.com, 805.795.4108)
• ·Media contact: BJ Koubaroulis (bj.koubaroulis@avinc.com, 747.324.5358)

13-04-2026

Hudson Technologies, Inc. (NASDAQ: HDSN) announced the appointment of Alan Sheriff and Jeffrey Feeler as independent directors effective April 13, 2026, bringing 40 years of capital markets expertise and over 30 years of operational experience in recycling and environmental services, respectively, to support strategic growth initiatives. The board accepted the resignation of Vincent Abbatecola effective April 10, 2026, after more than three decades of service. CEO Ken Gaglione praised the new directors' expertise and expressed gratitude for Abbatecola's foundational contributions.

• ·Alan Sheriff previously served as Vice Chairman of PNC Financial Services Group's Corporate & Institutional Bank and founded Solebury Capital.
• ·Jeffrey Feeler led US Ecology Inc. from 2006, becoming Chairman and CEO in 2013 until its 2022 sale.
• ·Filing items: 5.02 (Director/Officer Departure/Election), 7.01, 9.01.